Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome
To access this article, please choose from the options below
F.F. has nothing to disclose. D.P. has nothing to disclose. V.L. has nothing to disclose. D.P. has nothing to disclose. M.G. has nothing to disclose. A.R.G. has nothing to disclose.
PII: S0015-0282(09)03876-X
doi:10.1016/j.fertnstert.2009.10.016
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

